COVID-19 misinformation interventions should involve public health experts, establish consistent outcome measures and more to address health misinformation at individual, community and systems levels, according researchers of a recent study.
While there is potential in debunk interventions, accuracy prompt interventions, warning label interventions and combined interventions to address COVID-19 misinformation, many challenges exist in the study of health misinformation.
Authors of a study recently published in Health Affairs stressed that interventions should involve public health experts, establish consistent outcome measures, expand studies to visual formats, develop a typology of misinformation, test interventions globally and invest in more longitudinal research, in order to address health misinformation at individual, community and systems levels.
Previous research has shown that during the COVID-19 pandemic, misinformation shared online led to folks, globally, not following proper guidelines, increasing transmission and ultimately costing lives.
These acts of neglect included not wearing masks, refusal of vaccination or relying on ineffective alternative medicines to treat infection.
Governments, public health authorities and social media platforms made many efforts to curb the spread of misleading COVID-19 information.
However, the effectiveness of these efforts or interventions remains unclear.
Researchers of the systematic review published in Health Affairs attempted to identify the different kinds of COVID-19 misinformation interventions that have been studied and the extent to which they helped mitigate the impacts of COVID-19 misinformation.
Researchers reviewed 119 interventions that were published online from January 2020 to February 2023. Found was evidence supporting interventions like accuracy prompts, debunks and warning label attempts mitigating either the spread of or belief in COVID-19 misinformation.
However, the examination exposed significant hurdles in the current approach for investigating health misinformation on a broader scale.
For example, just 18% of COVID-19 misinformation interventions included outcome measures related to public health, such as vaccination intent.
In addition, authors identified a number of different outcome measures, limiting the ability to detect the overall impacts of interventions and to determine areas of concern for intervention strategies.
“Addressing many of the challenges identified in this review, such as including more public health experts in intervention design, standardizing outcome measures, and developing a misinformation typology, will make future evidence more comparable and actionable for public health,” the authors stated in the review. “There is no silver bullet for mitigating misleading health information…Health misinformation, similar to any public health issue, requires a multifaceted approach."
A Cup or Two of Joe a Day Could Keep COVID-19 Infection Away
November 19th 2023Coffee, rich in polyphenolic compounds like chlorogenic acid (CGA), caffeic acid (CAA), cafestol, melanoidins and trigonelline, has been recognized as a dominant source of CGA in various studies. Previous studies suggest that CGA in coffee can positively impact blood pressure, lipid profile, glycemia and insulin resistance.
Read More
In this episode, Peter Wehrwein, managing editor of Managed Healthcare Executive, speaks with Dr. Rodrigo Cerda. Dr. Cerda has been recently promoted to the position of senior vice president of health services and chief medical officer of Independence Blue Cross in Philadelphia. He is also a member of Managed Healthcare Executive’s editorial advisory board. Peter and Dr. Cerda discuss his new role at the Independence Blue Cross, what it means to be a chief medical officer at an insurer these days, valued-based care, social determinants of health, and, of course, the pandemic.
Listen
The risk of stroke is not as likely for adults 65 years and above who have taken the Pfizer-BioNTech and Moderna COVID-19 bivalent vaccines. However, there may be an elevated risk of stroke when COVID boosters are paired with high-dose flu vaccines, particularly in adults 85-years-old and above.
Read More
Briana Contreras, associate editor of MHE, spoke with Dr. Maria Hernandez, founder and CEO of Impact4Health. Maria shared not only how healthcare inequities remain to be an issue and what needs to be addressed, but also the progress that has been made over time through awareness, conversations and laws, especially due to the heightened awareness of inequities caused from the COVID-19 pandemic and the tragic deaths of George Floyd, Breonna Taylor and many more - which have now occurred over a year ago.
Listen
The Latest on Long COVID — Most Prevalent Symptoms to Research Underway | IDWeek 2023
October 12th 2023At this year’s ID Week conference in Boston, Igho Ofotokun, MD, MSc, FIDSA, Grady Distinguished Professor of Medicine at the Emory University School of Medicine, shared the latest data that COVID-19 research team, RECOVER, has gathered on Long COVID and its symptoms.
Read More
HHS Grants $45 Million to Long COVID Clinics to Transform Healthcare for Underserved Populations
September 21st 2023There are nine grant awards of $1 million each for up to 5 years — totaling to overall $45 million in grants — that would mainly support underserved, rural, vulnerable, and minority populations that are disproportionately impacted by the effects of Long COVID
Read More